Lupin is very bullish on the Indian market, see long-term opportunities: MD
New Delhi, Aug. 28 -- The last few years have not been easy for India's pharmaceuticals industry, with consolidation of buyers in the US and accompanying pricing pressure. In an interview, Nilesh Gupta, managing director of Lupin Ltd, said the company is bullish on the Indian market, which is growing very well. Edited excerpts:...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.